Kangmei Pharmaceutical Co., Ltd. (600518.SS) SHH

2.09

+0.01(+0.48%)

Updated at August 19 02:12PM

Currency In CNY

Valuation

Market Cap33.44B
Enterprise Value32.57B
P/E Ratio3,123.28
PEG Ratio-70.27
Price/Sales Ratio5.5
Price/Book Ratio4.18
Enterprise/Revenue5.36
Enterprise/EBITDA115.64

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0
Operating Margin-0

Management Effectiveness

Return On Assets0
Return On Equity0

Income Statement

Revenue5.19B
Revenue/Share0.37
Gross Profit766.99M
EBITDA396.02M
Net Income8.57M
Diluted EPS0

Balance Sheet

Total Cash894.22M
Total Cash/Share0.06
Total Debt120.92M
Total Debt/Equity0.02
Current Ratio1.18
Book Value Per Share0.51

Price History

52-Week Change14.13
52-Week High2.95
52-Week Low1.68
Moving Average 50 Days2.01
Moving Average 200 Days2.17

Statistics

Average Volume221.57M
Shares Outstanding13.83B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.08
Last Split Factor2:1
Last Split DateJune 16, 2015